anmelden
OMX Nordic 40
2.603,85
PKT
-30,09
PKT
-1,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.09.19 | Novo Nordisk Outperform | Bernstein Research | |
| 09.09.19 | AstraZeneca buy | Deutsche Bank AG | |
| 09.09.19 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 06.09.19 | AstraZeneca overweight | Barclays Capital | |
| 06.09.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 05.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 05.09.19 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 05.09.19 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 02.09.19 | Novo Nordisk buy | UBS AG | |
| 02.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 30.08.19 | A.P. Moeller - Maersk A-S (B) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.08.19 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 29.08.19 | Volvo (B) buy | Goldman Sachs Group Inc. | |
| 29.08.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 29.08.19 | Ericsson (Telefon L.M.Ericsson) (B) Outperform | Credit Suisse Group | |
| 29.08.19 | Nokia buy | UBS AG | |
| 29.08.19 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 29.08.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 28.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 28.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 28.08.19 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 27.08.19 | Fortum Equal weight | Barclays Capital | |
| 23.08.19 | Volvo (B) Underperform | Merrill Lynch & Co., Inc. | |
| 22.08.19 | Volvo (B) Sell | UBS AG | |
| 22.08.19 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 21.08.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 21.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.08.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 20.08.19 | A.P. Moeller - Maersk A-S (B) buy | HSBC | |
| 16.08.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 16.08.19 | AstraZeneca overweight | Barclays Capital | |
| 15.08.19 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 15.08.19 | A.P. Moeller - Maersk A-S (B) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.08.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 14.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 12.08.19 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 12.08.19 | Novo Nordisk Outperform | Credit Suisse Group |